Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis
2017 · New England Journal of Medicine · 995 citations
https://doi.org/10.1056/nejmoa1702079
M
Michael E. Wechsler
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
447
Papers
23.4K
Citations
75
h-index
199
i10-index
Michael E. Wechsler is an academic researcher from National Jewish Health. The author has contributed to research in topics: Asthma and respiratory diseases & Respiratory and Cough-Related Research & Eosinophilic Esophagitis. The author has an h-index of 75, co-authored 380 publications.
ORCID: 0000-0003-3505-2946Papers by this author
worksTezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma
2021 · New England Journal of Medicine · 884 citations
https://doi.org/10.1056/nejmoa2034975
Efficacy and Safety of Itepekimab in Patients with Moderate-to-Severe Asthma
2021 · New England Journal of Medicine · 386 citations
https://doi.org/10.1056/nejmoa2024257
Approaches to the treatment of hypereosinophilic syndromes: A workshop summary report
2006 · Journal of Allergy and Clinical Immunology · 345 citations
https://doi.org/10.1016/j.jaci.2006.02.042
Eosinophils in Health and Disease: A State-of-the-Art Review
2021 · Mayo Clinic Proceedings · 297 citations
https://doi.org/10.1016/j.mayocp.2021.04.025
Eosinophilic and Noneosinophilic Asthma
2021 · CHEST Journal · 243 citations
https://doi.org/10.1016/j.chest.2021.04.013
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat